Evaluation of annexins family as potential biomarker for predicting progression and prognosis in clear renal cell carcinoma

HIGHLIGHTS

  • who: Jiyu Zhao et al. from the Department of Urology, ChuiYangLiu Hospital Affiliated to Tsinghua University, Beijing, China have published the research work: Evaluation of Annexins Family as Potential Biomarker for Predicting Progression and Prognosis in Clear Renal Cell Carcinoma, in the Journal: Evidence-Based Complementary and Alternative Medicine 0.1 of 23/04/2022
  • what: Genetic variations of Annexins in 317 cases retrieved from four studies, including 35 cases from DanaFarber Cancer Institute (DFCI), 98 cases from Beijing Genomics Institute (BGI), 78 cases from Cancer Research UK London Research Institute (IRC), and 106 cases . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?